Gilead Sciences Announces $24 Million in Grants to Help End the HIV Epidemic for Everyone, Everywhere - InvestingNews.com

Funding Will Reach Under-Resourced Communities Most Impacted by the HIV Epidemic and COVID-19 Pandemic – Gilead Sciences, Inc., (Nasdaq: GILD) today announced $24 million in grants to help reduce health disparities, improve access to quality healthcare, adva…

Opdivo -based treatments have shown clinical benefit in four Phase 3 trials in earlier stages of cancer Bristol Myers Squibb (NYSE: BMY) today announced that the European Medicines Agency (EMA) ha… [+48346 chars]

full article...